Presence of Atrial Fibrillation at the Time of Dialysis Initiation Is Associated with Mortality and Cardiovascular Events

Nephron

Volumn 132, Issue 2, 2016, Pages 86-92

  Tanaka, Akihito ^a   Inaguma, Daijo ^a   Shinjo, Hibiki ^a   Murata, Minako ^a   Takeda, Asami ^a  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

Author keywords

Atrial fibrillation; Cardiovascular events; Chronic kidney disease; Dialysis; Mortality

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; WARFARIN;

AGED; ANTICOAGULANT THERAPY; AORTA DISEASE; ARTICLE; ATRIAL FIBRILLATION; BRAIN HEMORRHAGE; BRAIN INFARCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; HEART FAILURE; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; INCIDENCE; INDEPENDENT VARIABLE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; TIME TO TREATMENT; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT ANALYSIS; COMPLICATION; HEMODIALYSIS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84959219312     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000443314     Document Type: Article

References (19)

1. Nakai S, Hanafusa N, Masakane I, Taniguchi M, Hamano T, Shoji T, Hasegawa T, Itami N, Yamagata K, Shinoda T, Kazama JJ, Watanabe Y, Shigematsu T, Marubayashi S, Morita O, Wada A, Hashimoto S, Suzuki K, Nakamoto H, Kimata N, Wakai K, Fujii N, Ogata S, Tsuchida K, Nishi H, Iseki K, Tsubakihara Y: An overview of regular dialysis treatment in Japan (as of 31 December 2012). Ther Apher Dial 2014;18:535-602.
2. JCS Joint Working Group: Guidelines for pharmacotherapy of atrial fibrillation (JCS 2013). Circ J 2014;78:1997-2021.
3. Olesen JB, Lip GY, Kamper AL, Hommel K, Køber L, Lane DA, Lindhardsen J, Gislason GH, Torp-Pedersen C: Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med 2012;367:625-635.
4. Ezekowitz MD, Netrebko PI: Anticoagulation in management of atrial fibrillation. Curr Opin Cardiol 2003;18:26-31.
5. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D: Impact of atrial fibrillation on the risk of death: the Framingham heart study. Circulation 1998;98:946-952.
6. Kannel WB, Abbott RD, Savage DD, McNamara PM: Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982;306:1018-1022.
7. Carrero JJ, Evans M, Szummer K, Spaak J, Lindhagen L, Edfors R, Stenvinkel P, Jacobson SH, Jernberg T: Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation. JAMA 2014;311:919-928.
8. Lai HM, Aronow WS, Kalen P, Adapa S, Patel K, Goel A, Vinnakota R, Chugh S, Garrick R: Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin. Int J Nephrol Renovasc Dis 2009;2:33-37.
9. Wizemann V, Tong L, Satayathum S, Disney A, Akiba T, Fissell RB, Kerr PG, Young EW, Robinson BM: Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. Kidney Int 2010;77:1098-1106.
10. Friberg L, Benson L, Lip GY: Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish atrial fibrillation cohort study. Eur Heart J 2015;36:297-306.
11. Sueta S, Morozumi K, Takeda A, Horike K, Otsuka Y, Shinjo H, Murata M, Kato Y, Goto K, Inaguma D; Aichi Cohort Study of Prognosis in Patients Newly Initiated Into Dialysis (AICOPP) Study Group: Ability of vitamin D receptor activator to prevent pulmonary congestion in advanced chronic kidney disease. Clin Exp Nephrol 2015;19:371-378.
12. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982-992.
13. Soliman EZ, Prineas RJ, Go AS, Xie D, Lash JP, Rahman M, Ojo A, Teal VL, Jensvold NG, Robinson NL, Dries DL, Bazzano L, Mohler ER, Wright JT, Feldman HI: Chronic kidney disease and prevalent atrial fibrillation: the chronic renal insufficiency cohort (CRIC). Am Heart J 2010;159:1102-1107.
14. Atar I, Konaş D, Açikel S, Külah E, Atar A, Bozbaş H, Gülmez O, Sezer S, Yildirir A, Ozdemir N, Müderrisoʇlu H, Ozin B: Frequency of atrial fibrillation and factors related to its development in dialysis patients. Int J Cardiol 2006;106:47-51.
15. Eckardt KU, Gillespie IA, Kronenberg F, Richards S, Stenvinkel P, Anker SD, Wheeler DC, de Francisco AL, Marcelli D, Froissart M, Floege J; ARO Steering Committee: High cardiovascular event rates occur within the first weeks of starting hemodialysis. Kidney Int 2015;88:1117-1125.
16. Chan KE, Lazarus JM, Thadhani R, Hakim RM: Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol 2009;20:2223-2233.
17. Shah M, Avgil Tsadok M, Jackevicius CA, Essebag V, Eisenberg MJ, Rahme E, Humphries KH, Tu JV, Behlouli H, Guo H, Pilote L: Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis. Circulation 2014;129:1196-1203.
18. Yang JY, Lee TC, Montez-Rath ME, Paik J, Chertow GM, Desai M, Winkelmayer WC: Trends in acute nonvariceal upper gastrointestinal bleeding in dialysis patients. J Am Soc Nephrol 2012;23:495-506.
19. Iseki K, Kinjo K, Kimura Y, Osawa A, Fukiyama K: Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int 1993;44:1086-1090.